Literature DB >> 35613648

Buprenorphine uptake during pregnancy following the 2017 guidelines update on prenatal opioid use disorder.

Max Jordan Nguemeni Tiako1, Angelica Meinhofer2, Ari Friedman3, Eugenia C South4, Rachel L Epstein5, Zachary F Meisel6, Jake R Morgan7.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35613648      PMCID： PMC9420821          DOI： 10.1016/j.ajog.2022.05.041

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN： 0002-9378            Impact factor:   10.693


× No keyword cloud information.
  5 in total

1.  Predictors of Initiation of Medication for Opioid Use Disorder and Retention in Treatment Among U.S. Pregnant Women, 2013-2017.

Authors:  Max Jordan Nguemeni Tiako; Ari Friedman; Jennifer Culhane; Eugenia South; Zachary F Meisel
Journal:  Obstet Gynecol       Date:  2021-04-01       Impact factor: 7.661

2.  Neonatal Abstinence Syndrome and Maternal Opioid-Related Diagnoses in the US, 2010-2017.

Authors:  Ashley H Hirai; Jean Y Ko; Pamela L Owens; Carol Stocks; Stephen W Patrick
Journal:  JAMA       Date:  2021-01-12       Impact factor: 56.272

3.  Committee Opinion No. 711: Opioid Use and Opioid Use Disorder in Pregnancy.

Authors: 
Journal:  Obstet Gynecol       Date:  2017-08       Impact factor: 7.661

4.  Prevalence and Geographic Distribution of Obstetrician-Gynecologists Who Treat Medicaid Enrollees and Are Trained to Prescribe Buprenorphine.

Authors:  Max Jordan Nguemeni Tiako; Jennifer Culhane; Eugenia South; Sindhu K Srinivas; Zachary F Meisel
Journal:  JAMA Netw Open       Date:  2020-12-01

5.  Association of Pregnancy and Insurance Status With Treatment Access for Opioid Use Disorder.

Authors:  Stephen W Patrick; Michael R Richards; William D Dupont; Elizabeth McNeer; Melinda B Buntin; Peter R Martin; Matthew M Davis; Corey S Davis; Katherine E Hartmann; Ashley A Leech; Kim S Lovell; Bradley D Stein; William O Cooper
Journal:  JAMA Netw Open       Date:  2020-08-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.